1. Home
  2. Pharma & Healthcare
  3. Global Non-Invasive Prenatal Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Non-Invasive Prenatal Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 102 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Non-Invasive Prenatal Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Non-Invasive Prenatal Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Non-Invasive Prenatal Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Non-Invasive Prenatal Testing market has been segmented into:
High & Average Risk
Low Risk

By Application, Non-Invasive Prenatal Testing has been segmented into:
0-12 weeks
13-24 weeks
25-36 weeks

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Invasive Prenatal Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Invasive Prenatal Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Invasive Prenatal Testing market.

The report offers in-depth assessment of the growth and other aspects of the Non-Invasive Prenatal Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Non-Invasive Prenatal Testing Market Share Analysis
Non-Invasive Prenatal Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-Invasive Prenatal Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Invasive Prenatal Testing sales, revenue and market share for each player covered in this report.

The major players covered in Non-Invasive Prenatal Testing are:
Sequenom
Berry Genomics
LabCorp
Roche
Illumina
Natera
Quest Diagnostics
BGI Genomics

Table of Contents

1 Non-Invasive Prenatal Testing Market Overview
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing
1.2 Classification of Non-Invasive Prenatal Testing by Type
1.2.1 Global Non-Invasive Prenatal Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Type in 2019
1.2.3 High & Average Risk
1.2.4 Low Risk
1.3 Global Non-Invasive Prenatal Testing Market by Application
1.3.1 Overview: Global Non-Invasive Prenatal Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 0-12 weeks
1.3.3 13-24 weeks
1.3.4 25-36 weeks
1.4 Global Non-Invasive Prenatal Testing Market by Regions
1.4.1 Global Non-Invasive Prenatal Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non-Invasive Prenatal Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sequenom
2.1.1 Sequenom Details
2.1.2 Sequenom Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sequenom SWOT Analysis
2.1.4 Sequenom Product and Services
2.1.5 Sequenom Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Berry Genomics
2.2.1 Berry Genomics Details
2.2.2 Berry Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Berry Genomics SWOT Analysis
2.2.4 Berry Genomics Product and Services
2.2.5 Berry Genomics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LabCorp SWOT Analysis
2.3.4 LabCorp Product and Services
2.3.5 LabCorp Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina SWOT Analysis
2.5.4 Illumina Product and Services
2.5.5 Illumina Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Natera
2.6.1 Natera Details
2.6.2 Natera Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Natera SWOT Analysis
2.6.4 Natera Product and Services
2.6.5 Natera Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quest Diagnostics SWOT Analysis
2.7.4 Quest Diagnostics Product and Services
2.7.5 Quest Diagnostics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 BGI Genomics
2.8.1 BGI Genomics Details
2.8.2 BGI Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BGI Genomics SWOT Analysis
2.8.4 BGI Genomics Product and Services
2.8.5 BGI Genomics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non-Invasive Prenatal Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Invasive Prenatal Testing Players Market Share
3.2.2 Top 10 Non-Invasive Prenatal Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non-Invasive Prenatal Testing Revenue and Market Share by Regions
4.2 North America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.5 South America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5 North America Non-Invasive Prenatal Testing Revenue by Countries
5.1 North America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
5.2 USA Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6 Europe Non-Invasive Prenatal Testing Revenue by Countries
6.1 Europe Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
6.2 Germany Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.3 UK Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.4 France Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non-Invasive Prenatal Testing Revenue by Countries
7.1 Asia-Pacific Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
7.2 China Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.5 India Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
8 South America Non-Invasive Prenatal Testing Revenue by Countries
8.1 South America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
8.2 Brazil Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non-Invasive Prenatal Testing by Countries
9.1 Middle East & Africa Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non-Invasive Prenatal Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Non-Invasive Prenatal Testing Market Forecast by Type (2019-2024)
10.3 High & Average Risk Revenue Growth Rate (2015-2025)
10.4 Low Risk Revenue Growth Rate (2015-2025)
11 Global Non-Invasive Prenatal Testing Market Segment by Application
11.1 Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2015-2020)
11.2 Non-Invasive Prenatal Testing Market Forecast by Application (2019-2024)
11.3 0-12 weeks Revenue Growth (2015-2020)
11.4 13-24 weeks Revenue Growth (2015-2020)
11.5 25-36 weeks Revenue Growth (2015-2020)
12 Global Non-Invasive Prenatal Testing Market Size Forecast (2021-2025)
12.1 Global Non-Invasive Prenatal Testing Market Size Forecast (2021-2025)
12.2 Global Non-Invasive Prenatal Testing Market Forecast by Regions (2021-2025)
12.3 North America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.4 Europe Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.6 South America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Non-Invasive Prenatal Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Invasive Prenatal Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non-Invasive Prenatal Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sequenom Corporate Information, Location and Competitors
Table 6. Sequenom Non-Invasive Prenatal Testing Major Business
Table 7. Sequenom Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 8. Sequenom SWOT Analysis
Table 9. Sequenom Non-Invasive Prenatal Testing Product and Solutions
Table 10. Sequenom Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Berry Genomics Corporate Information, Location and Competitors
Table 12. Berry Genomics Non-Invasive Prenatal Testing Major Business
Table 13. Berry Genomics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2018-2019)
Table 14. Berry Genomics SWOT Analysis
Table 15. Berry Genomics Non-Invasive Prenatal Testing Product and Solutions
Table 16. Berry Genomics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. LabCorp Corporate Information, Location and Competitors
Table 18. LabCorp Non-Invasive Prenatal Testing Major Business
Table 19. LabCorp Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 20. LabCorp SWOT Analysis
Table 21. LabCorp Non-Invasive Prenatal Testing Product and Solutions
Table 22. LabCorp Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Non-Invasive Prenatal Testing Major Business
Table 25. Roche Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Non-Invasive Prenatal Testing Product and Solutions
Table 28. Roche Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Illumina Corporate Information, Location and Competitors
Table 30. Illumina Non-Invasive Prenatal Testing Major Business
Table 31. Illumina Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 32. Illumina SWOT Analysis
Table 33. Illumina Non-Invasive Prenatal Testing Product and Solutions
Table 34. Illumina Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Natera Corporate Information, Location and Competitors
Table 36. Natera Non-Invasive Prenatal Testing Major Business
Table 37. Natera Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 38. Natera SWOT Analysis
Table 39. Natera Non-Invasive Prenatal Testing Product and Solutions
Table 40. Natera Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Quest Diagnostics Corporate Information, Location and Competitors
Table 42. Quest Diagnostics Non-Invasive Prenatal Testing Major Business
Table 43. Quest Diagnostics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 44. Quest Diagnostics SWOT Analysis
Table 45. Quest Diagnostics Non-Invasive Prenatal Testing Product and Solutions
Table 46. Quest Diagnostics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BGI Genomics Corporate Information, Location and Competitors
Table 48. BGI Genomics Non-Invasive Prenatal Testing Major Business
Table 49. BGI Genomics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 50. BGI Genomics SWOT Analysis
Table 51. BGI Genomics Non-Invasive Prenatal Testing Product and Solutions
Table 52. BGI Genomics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Players (2015-2020)
Table 54. Global Non-Invasive Prenatal Testing Revenue Share by Players (2015-2020)
Table 55. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions (2015-2020)
Table 57. North America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
Table 58. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 59. Europe Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
Table 62. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 65. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Type (2015-2020)
Table 66. Global Non-Invasive Prenatal Testing Revenue Share by Type (2015-2020)
Table 67. Global Non-Invasive Prenatal Testing Revenue Forecast by Type (2021-2025)
Table 68. Global Non-Invasive Prenatal Testing Revenue by Application (2015-2020)
Table 69. Global Non-Invasive Prenatal Testing Revenue Share by Application (2015-2020)
Table 70. Global Non-Invasive Prenatal Testing Revenue Forecast by Application (2021-2025)
Table 71. Global Non-Invasive Prenatal Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Non-Invasive Prenatal Testing Picture
Figure 2. Global Non-Invasive Prenatal Testing Revenue Market Share by Type in 2019
Figure 3. High & Average Risk Picture
Figure 4. Low Risk Picture
Figure 5. Non-Invasive Prenatal Testing Revenue Market Share by Application in 2019
Figure 6. 0-12 weeks Picture
Figure 7. 13-24 weeks Picture
Figure 8. 25-36 weeks Picture
Figure 9. Global Non-Invasive Prenatal Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Non-Invasive Prenatal Testing Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Non-Invasive Prenatal Testing Revenue Market Share in 2019
Figure 18. Global Top 10 Players Non-Invasive Prenatal Testing Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions (2015-2020)
Figure 22. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions in 2018
Figure 23. North America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 24. Europe Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 26. South America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 28. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 29. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 30. USA Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 31. Canada Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 35. Germany Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 36. UK Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 37. France Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 38. Russia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 39. Italy Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 42. China Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 43. Japan Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 44. Korea Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 45. India Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 47. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 48. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 49. Brazil Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 54. UAE Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 57. Global Non-Invasive Prenatal Testing Revenue Share by Type (2015-2020)
Figure 58. Global Non-Invasive Prenatal Testing Revenue Share by Type in 2019
Figure 59. Global Non-Invasive Prenatal Testing Market Share Forecast by Type (2021-2025)
Figure 60. Global High & Average Risk Revenue Growth Rate (2015-2020)
Figure 61. Global Low Risk Revenue Growth Rate (2015-2020)
Figure 62. Global Non-Invasive Prenatal Testing Revenue Share by Application (2015-2020)
Figure 63. Global Non-Invasive Prenatal Testing Revenue Share by Application in 2019
Figure 64. Global Non-Invasive Prenatal Testing Market Share Forecast by Application (2021-2025)
Figure 65. Global 0-12 weeks Revenue Growth Rate (2015-2020)
Figure 66. Global 13-24 weeks Revenue Growth Rate (2015-2020)
Figure 67. Global 25-36 weeks Revenue Growth Rate (2015-2020)
Figure 68. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Non-Invasive Prenatal Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Non-Invasive Prenatal Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 72. Europe Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 74. South America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Sequenom
Berry Genomics
LabCorp
Roche
Illumina
Natera
Quest Diagnostics
BGI Genomics

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets